1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Adoption of highly effective methods for screening test processes.
4.1.2 Increasing awareness among the people and consumers.
4.1.3 Increase in pipeline breast cancer screening tests.
4.2. Restraints
4.2.1 Higher screening test process.
4.2.2 Economic uncertainty and reimbursement issues.
4.3. Opportunities
4.3.1 Newer technological developments and approaches.
4.4. Challenges
4.4.1. Innovative medicines and new mechanisms of action to enhance the enthusiasm about major approaches in cancer treatments.
5. North America Breast Cancer Screening Test Market - By Tests
5.1 Introduction
5.2 Blood marker tests
5.3 Imaging tests
5.3.1 Mammograms
5.3.2 MRI
5.3.3 Ultrasound
5.3.4 Mamma print test
5.4 Genetic tests
5.4.1 Fluorescence in-situ hybridisation
5.4.2 HER gene test
5.5 Immunohistochemistry
6. North America Breast Cancer Screening Test Market - By End-user
6.1 Introduction
6.2 Hospitals
6.3 Diagnostics centres
6.4 Cancer institutes
6.5 Research laboratories
7. North America Breast Cancer Screening Test Market – By Country
7.1 North America
7.1.1 Introduction
7.1.2 Middle East
7.1.3 Africa
8. North America Breast Cancer Screening Test Market - Company Profiles
8.1 GE healthcare
8.2 Siemens healthcare
8.3 Cardinal health care
8.4 Nordion Inc.
8.5 Triad isotope
8.6 Eczacibasi Monrol nuclear products
8.7 Mallinckrodt Plc
8.8 Bracco imaging S.p.A
8.9 Advanced accelerator applications SA
8.10 Lantheus medical imaging Inc.
8.11 IBA molecular imaging
8.12 Bayer healthcare
8.13 Siemens healthcare
9. North America Breast Cancer Screening Market - Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
11. Appendix
11.1. List of tables
11.2. List of figures
